造价刺激阻塞和固体器官移植:过去,现在和未来
William H Kitchens1, Christian P Larsen1, I Raul Badell1
1Division of Transplantation, Department of Surgery, Emory University School of Medicine, Atlanta, Georgia, USA.
Kidney international reports
|December 18, 2023
概括
贝拉塔塞普特为移植患者提供了优越的长期存活率,但由于拒绝风险和管理问题,它面临着采用挑战. 正在探索改善其使用的策略.
科学领域:
- 免疫学 免疫学 免疫学
- 移植医学 移植医学
- 药理学 药理学是指药理学的学科.
背景情况:
- 贝拉塔塞普特是第一个批准用于移植免疫抑制的共刺激性阻断剂.
- 与基于氨尿素抑制剂 (CNI) 的疗法相比,它显示出优异的长期代移植和患者存活率.
- 临床采用受到急性细胞排斥 (ACR) 和管理障碍的担忧所限制.
研究的目的:
- 审查belatacept的临床开发和批准.
- 检查新的无CNI治疗方案和策略,以减轻ACR风险.
- 探索未来的途径,以增加belatacept的采用和扩大其指示.
主要方法:
- 对临床试验数据的审查,包括BENEFIT和BENEFIT-EXT试验.
- 对基于贝拉塔塞普的免疫抑制药物临床经验的分析,包括CNI缓解方法.
- 讨论了后勤改进和扩大了belatacept的指示.
主要成果:
- 贝拉塔塞普在移植中提供长期生存益处.
- 对早期ACR和管理物流的担忧阻碍了广泛使用.
- 像CNI逐渐减少和探索皮下注射等策略显示出有希望.
结论:
- 贝拉塔塞普特提供了显著的长期益处,但需要战略来克服采用障碍.
- 优化管理和扩大适应症可能会增加其临床效用.
- 未来对新型免疫抑制剂的研究可能会进一步加强共刺激阻塞的使用.
相关概念视频
Tissue Transplantation
373
Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
373
Cell-mediated Immune Responses
68.3K
Overview
68.3K
Bone Marrow Sampling and Transplants
333
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
333
Regulation of Hematopoietic Stem Cells
3.2K
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
3.2K


